title: [Drug-induced movement disorders: tardive syndromes].
abstract: Persistent drug-induced movement disorders (tardive syndromes) remain an important clinical problem and consist of a variety of involuntary movements appearing in a patient exposed to a dopamine-blocking agent. The current state of knowledge on this topic is summarised in this article. Clinical aspects (tardive dyskinesia, tardive dystonia and other forms), prevalence, risk factors, prevention and management are discussed.
authors.affiliation: Service de Pharmacologie Médicale et Toxicologie, Hôpital Lapeyronie, CHU de Montpellier, 34295 Montpellier, France. jp-blayac@chu-montpellier.fr
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Blayac
authors.forename: Véronique
authors.initials: V
authors.lastname: Pinzani
authors.forename: Hélène
authors.initials: H
authors.lastname: Peyrière
authors.forename: Dominique
authors.initials: D
authors.lastname: Hillaire-Buys
mesh_terms: D017109:Akathisia, Drug-Induced / Q000503:physiopathology; D018492:Dopamine Antagonists / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology* / Q000628:therapy; D004421:Dystonia / Q000139:chemically induced / Q000503:physiopathology; D006801:Humans; D009207:Myoclonus / Q000139:chemically induced; D011954:Receptors, Dopamine / Q000187:drug effects; D012701:Serotonin / Q000502:physiology; D020323:Tics / Q000139:chemically induced; D014202:Tremor / Q000139:chemically induced
chemical_list: D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D012701:Serotonin